Access site bleeding after transcatheter aortic valve implantation

Area of Science:

• Cardiology
• Interventional Cardiology
• Cardiac Surgery

Background:

• Severe aortic stenosis (AS) significantly impacts morbidity and mortality.
• Surgical aortic valve replacement is the standard for symptomatic patients.
• A substantial portion of severe AS patients are inoperable due to high surgical risk.

Purpose of the Study:

• To systematically review access site complications associated with transcatheter aortic valve implantation (TAVI).
• To identify and evaluate approaches for minimizing TAVI-related access site complications.

Main Methods:

• Systematic review of literature on TAVI procedures.
• Analysis of reported access site complications and their management.
• Evaluation of techniques aimed at reducing bleeding events.

Main Results:

• Transcatheter aortic valve implantation (TAVI) improves survival and quality of life in high-risk, inoperable patients.
• Access site bleeding is a significant complication following TAVI.
• Bleeding complications are linked to adverse clinical outcomes.

Conclusions:

• TAVI is a viable option for inoperable severe aortic stenosis patients.
• Minimizing access site complications is critical for improving TAVI outcomes.
• Further research into preventative strategies for bleeding is warranted.